Novel Rinse to Treat in Oral Candidiasis in Cancer Patients
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy of Iocide oral rinse as a treatment for
Oral Candidiasis in any patient including but not limited to patients receiving radiation
therapy or who have previously received radiation therapy for head and neck cancer, or
patients positive for HIV/AIDS or are transplant patients.
Details
Lead Sponsor:
Biomedical Development Corporation
Collaborators:
National Institute of Dental and Craniofacial Research (NIDCR) University of Texas